Suppr超能文献

相似文献

1
Deregulation of E2-EPF ubiquitin carrier protein in papillary renal cell carcinoma.
Am J Pathol. 2011 Feb;178(2):853-60. doi: 10.1016/j.ajpath.2010.10.033.
2
pVHL's kryptonite: E2-EPF UCP.
Cancer Cell. 2006 Aug;10(2):95-7. doi: 10.1016/j.ccr.2006.07.016.
3
Hypoxia-inducible factor 1α mediates the down-regulation of superoxide dismutase 2 in von Hippel-Lindau deficient renal clear cell carcinoma.
Biochem Biophys Res Commun. 2013 May 24;435(1):46-51. doi: 10.1016/j.bbrc.2013.04.034. Epub 2013 Apr 20.
6
E2-EPF UCP targets pVHL for degradation and associates with tumor growth and metastasis.
Nat Med. 2006 Jul;12(7):809-16. doi: 10.1038/nm1440. Epub 2006 Jul 2.

引用本文的文献

1
Diverse roles of UBE2S in cancer and therapy resistance: Biological functions and mechanisms.
Heliyon. 2024 Jan 18;10(2):e24465. doi: 10.1016/j.heliyon.2024.e24465. eCollection 2024 Jan 30.
4
Differential Activation of NRF2 Signaling Pathway in Renal-Cell Carcinoma Caki Cell Lines.
Biomedicines. 2023 Mar 24;11(4):1010. doi: 10.3390/biomedicines11041010.
6
UBE2S promotes cell chemoresistance through PTEN-AKT signaling in hepatocellular carcinoma.
Cell Death Discov. 2021 Nov 16;7(1):357. doi: 10.1038/s41420-021-00750-3.
7
UBE2S activates NF-κB signaling by binding with IκBα and promotes metastasis of lung adenocarcinoma cells.
Cell Oncol (Dordr). 2021 Dec;44(6):1325-1338. doi: 10.1007/s13402-021-00639-4. Epub 2021 Sep 28.
9
Prognostic Role of the Ubiquitin Proteasome System in Clear Cell Renal Cell Carcinoma: A Bioinformatic Perspective.
J Cancer. 2021 May 13;12(14):4134-4147. doi: 10.7150/jca.53760. eCollection 2021.
10
Dimerization regulates the human APC/C-associated ubiquitin-conjugating enzyme UBE2S.
Sci Signal. 2020 Oct 20;13(654):eaba8208. doi: 10.1126/scisignal.aba8208.

本文引用的文献

1
VHL and HIF signalling in renal cell carcinogenesis.
J Pathol. 2010 Jun;221(2):125-38. doi: 10.1002/path.2689.
2
Cancer statistics, 2009.
CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49. doi: 10.3322/caac.20006. Epub 2009 May 27.
3
The clinical implications of the genetics of renal cell carcinoma.
Urol Oncol. 2009 Mar-Apr;27(2):131-6. doi: 10.1016/j.urolonc.2008.11.001.
4
Renal cell carcinoma.
Lancet. 2009 Mar 28;373(9669):1119-32. doi: 10.1016/S0140-6736(09)60229-4. Epub 2009 Mar 5.
5
Cytogenetic and molecular tumor profiling for type 1 and type 2 papillary renal cell carcinoma.
Clin Cancer Res. 2009 Feb 15;15(4):1162-9. doi: 10.1158/1078-0432.CCR-08-1229.
9
Efficacy of sunitinib and sorafenib in metastatic papillary and chromophobe renal cell carcinoma.
J Clin Oncol. 2008 Jan 1;26(1):127-31. doi: 10.1200/JCO.2007.13.3223.
10
Beyond the hypoxia-inducible factor-centric tumour suppressor model of von Hippel-Lindau.
Curr Opin Oncol. 2008 Jan;20(1):83-9. doi: 10.1097/CCO.0b013e3282f310de.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验